Pemetrexed and Carboplatin (PC) Regimen

doi:10.1310/hpj4411-946

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and investigational, used to treat malignant diseases.

Authors

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

unpaywall

Confidence 95%

datacite

Confidence 0%

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

10.1200/jco.2006.07.7016

10.1158/1078-0432.690.11.2

10.1158/1078-0432.690.11.2 · 2005

10.1002/cncr.21480

10.1200/jco.2008.19.1650

10.1200/jco.2008.20.9114

10.1200/jco.2005.04.3190

10.1093/annonc/mdm501

10.1097/jto.0b013e31817c73d6

10.1016/j.lungcan.2008.08.013

10.1007/s10549-007-9722-5

10.1200/jco.2008.17.0282

Unresolved referenced work

Pemetrexed and Carboplatin (PC) Regimen

Referenced works

Cited by

External reference records

Additional external references